<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:media="http://search.yahoo.com/mrss/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medicines &#8211; USA NEWS LIVE</title>
	<atom:link href="https://bloggingthree.soflytech.com/tag/medicines/feed/" rel="self" type="application/rss+xml" />
	<link>https://bloggingthree.soflytech.com</link>
	<description>All About USA NEWS</description>
	<lastBuildDate>Mon, 06 Jan 2025 15:17:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://bloggingthree.soflytech.com/wp-content/uploads/2024/04/cropped-THE-USA1-e1713184454543-1-32x32.png</url>
	<title>Medicines &#8211; USA NEWS LIVE</title>
	<link>https://bloggingthree.soflytech.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Microbes can colonize space, produce medicines and generate energy &#8211; researchers are simulating their inner workings to benefit from this</title>
		<link>https://bloggingthree.soflytech.com/2025/01/microbes-can-colonize-space-produce-medicines-and-generate-energy-researchers-are-simulating-their-inner-workings-to-benefit-from-this/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Mon, 06 Jan 2025 15:17:33 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[advantage]]></category>
		<category><![CDATA[colonize]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[generate]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[microbes]]></category>
		<category><![CDATA[produce]]></category>
		<category><![CDATA[researchers]]></category>
		<category><![CDATA[simulating]]></category>
		<category><![CDATA[space]]></category>
		<category><![CDATA[workings]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=22167</guid>

					<description><![CDATA[After spending so a few years learning how microbes work, researchers are actually digitally recreating their inner workings to unravel challenges resembling: Climate change To Space colonization. In my work as Computational biologistI&#8217;m researching ways to get microbes to provide more useful chemicals resembling fuels and bioplastics that may be utilized in the energy, agricultural [&#8230;]]]></description>
										<content:encoded><![CDATA[<p></p>
<div itemprop="articleBody">
<p>After spending so a few years learning how microbes work, researchers are actually digitally recreating their inner workings to unravel challenges resembling: <a href="https://doi.org/10.1038/nprot.2009.203">Climate change</a> To <a href="https://doi.org/10.1016/j.mimet.2022.106459">Space colonization</a>.</p>
<p>In my work as <a href="https://scholar.google.com/citations?user=Ip7mrm0AAAAJ&#038;hl=en">Computational biologist</a>I&#8217;m researching ways to get microbes to provide more useful chemicals resembling fuels and bioplastics that may be utilized in the energy, agricultural or pharmaceutical industries. Traditionally, researchers need to conduct multiple trial-and-error experiments on Petri dishes to find out the optimal conditions microbes need to provide large amounts of chemicals. </p>
<p>Instead, I&#8217;m capable of simulate these experiments all behind a pc screen using digital blueprints that recreate the insides of microbes. Called <a href="https://doi.org/10.3390/metabo12010014">Genome-scale metabolic models or GEMs</a>These virtual labs significantly reduce the time and price required to work out what researchers have to do to get what they&#8217;re on the lookout for. With GEMs, researchers cannot only explore the complex network of metabolic pathways that enable living organisms to operate, but in addition optimize, test and predict how microbes would behave in several environments, including on other planets. </p>
<p>As GEM technology continues to develop, I consider these models will play an increasingly vital role in shaping the longer term of biotechnology, medicine and space exploration.</p>
<h2>What are genome-scale metabolic models?</h2>
<p><a href="https://doi.org/10.1038/nprot.2009.203">Genome-scale metabolic models</a> are digital maps of all known chemical reactions that happen in cells &#8211; i.e. the cell&#39;s metabolism. These reactions are crucial for converting food into energy, constructing cell structures and detoxifying pollutants. </p>
<p>To create a GEM, I first analyze an organism&#39;s genome, which accommodates the genetic instructions that cells use to provide proteins. A kind of protein encoded within the genome <a href="https://www.genome.gov/genetics-glossary/Enzyme">so-called enzymes</a> are the workhorses of metabolism – they facilitate the conversion of nutrients into energy and constructing blocks for cells. </p>
<p>By linking the genes that encode enzymes to the chemical reactions they allow, I can create a comprehensive model that maps the connections between genes, reactions, and metabolites.</p>
<figure class="align-center zoomable">
<div class="placeholder-container" style="--aspect-ratio-percent:75.06631299734748%;--background-color:#9ca15e"><img decoding="async" alt="Diagram made of multicolored intersecting lines and circles, similar to a subway map" class="lazyload" src="https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;fit=clip" srcset="https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=600&#038;h=450&#038;fit=crop&#038;dpr=1 600w, https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=600&#038;h=450&#038;fit=crop&#038;dpr=2 1200w, https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=600&#038;h=450&#038;fit=crop&#038;dpr=3 1800w, https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=45&#038;auto=format&#038;w=754&#038;h=566&#038;fit=crop&#038;dpr=1 754w, https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=30&#038;auto=format&#038;w=754&#038;h=566&#038;fit=crop&#038;dpr=2 1508w, https://images.theconversation.com/files/633673/original/file-20241121-15-sq25lf.jpg?ixlib=rb-4.1.0&#038;q=15&#038;auto=format&#038;w=754&#038;h=566&#038;fit=crop&#038;dpr=3 2262w" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px"></div><figcaption>
              <span class="caption">This map shows just a few of an important metabolic pathways in cells.</span><br />
              <span class="attribution"><a class="source" href="https://commons.wikimedia.org/wiki/File:Metabolic_Metro_Map.svg">Source/Wikimedia Commons</a></span><br />
            </figcaption></figure>
<p>Once I construct a GEM, I exploit some advanced computer simulations to make it function like a living cell or microbe. One of essentially the most common algorithms researchers use to perform these simulations is named a <a href="https://doi.org/10.1038/nbt.1614">Flow balance evaluation</a>. This mathematical algorithm analyzes available data about metabolism after which makes predictions about how various chemical reactions and metabolites would behave under certain conditions.</p>
<p>This makes GEMs particularly useful for understanding how organisms reply to genetic changes and environmental stresses. For example, I can use this method to predict how an organism will react if a specific gene is switched off. I could also use it to predict how it would adapt to the presence of various chemicals in its environment or to an absence of food.</p>
<h2>Solving energy and climate challenges</h2>
<p>Most chemicals utilized in agriculture, pharmaceuticals and fuels are <a href="https://www.wri.org/insights/defossilizing-us-chemical-production">obtained from fossil fuels</a>. However, fossil fuels are a limited resource and <a href="https://science.nasa.gov/climate-change/causes/">contribute significantly</a> on climate change. </p>
<p>Instead of generating energy from fossil fuels, my team&#8230; <a href="https://www.glbrc.org/">Great Lakes Bioenergy Research Center</a> from the University of Wisconsin-Madison focuses on developing sustainable biofuels and bioproducts from plant waste. This includes corn stalks after the ears have been harvested, inedible plants resembling grass and algae. We study which plant waste may be used for bioenergy, the way to convert it into energy using microbes, and the way to sustainably manage the land on which these plants are grown.</p>
<p>I&#39;m constructing a genome-scale metabolic model for <a href="https://doi.org/10.3390/metabo12040366"></a>a kind of bacteria that may do this <a href="https://doi.org/10.1128/aem.01268-23">convert very complex chemicals</a> in plant waste <a href="https://doi.org/10.1128/aem.01660-23">Chemicals which can be helpful to humans</a>for instance, those used to provide bioplastics, pharmaceuticals and fuels. With a greater understanding of this conversion process, I can improve the model to more accurately simulate the conditions required to synthesize larger quantities of those chemicals. </p>
<p>Researchers can then replicate these conditions in real life to create materials which can be cheaper and more accessible than those constructed from fossil fuels.</p>
<figure>
<p><iframe title="Bioinformatics: How Data Saves Lives: Crash Course Biology #40" width="1170" height="658" src="https://www.youtube.com/embed/o-WFU5ovaTc?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe></p><figcaption><span class="caption">Bioinformatics analyzes biological data to reply questions on living organisms.</span></figcaption></figure>
<h2>Extreme microbial and space colonization</h2>
<p>There are microbes on Earth that may survive in extremely harsh environments. For example, <a href="https://doi.org/10.1002/mbo3.1328"></a>    can live in extremely salty conditions. Similar, <a href="https://doi.org/10.1016/j.mimet.2022.106459"></a>    can thrive in very acidic environments.</p>
<p>Since other planets typically have similarly harsh climates, these microbes may not only have the option to thrive and multiply on those planets, but could also potentially change the environment in order that humans can live there too. </p>
<p>By combining GEMs with machine learning, I even have seen and may do that <a href="https://doi.org/10.1002/biot.202400267">subject to chemical changes</a> that help them survive in extreme conditions. They have special proteins of their cell partitions that work with enzymes to balance the chemicals of their internal environment with the chemicals of their external environment.</p>
<p>GEMs allow scientists to simulate the environments of other planets to check how microbes survive without necessarily having to go to those planets themselves.</p>
<h2>The way forward for GEMs</h2>
<p>Every day, researchers generate large amounts of knowledge about microbial metabolism. Advances in GEM technology open the door to exciting latest possibilities in medicine, energy, space travel and other areas.</p>
<p><a href="https://doi.org/10.1016/j.tibtech.2024.02.008">Synthetic biologists</a> can use GEMs to design entirely latest organisms or metabolic pathways from scratch. This area could advance bioproduction by enabling the creation of organisms that efficiently produce latest materials, medicines and even food. </p>
<p>GEMs of the whole human body may function <a href="https://doi.org/10.1126/scisignal.aaz1482">Atlas for the metabolism of complex diseases</a>. They can assist map how the body&#39;s chemical environment changes with obesity or diabetes.</p>
<p>Whether producing biofuels or developing latest organisms, GEMs represent a strong tool for each basic research and industrial applications. As computational biology and GEMs advance, these technologies will proceed to rework the best way scientists do the Understanding and manipulating the metabolism of living organisms.</p>
</p></div>
<p><em>image credit : theconversation.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://images.theconversation.com/files/633667/original/file-20241121-17-70pvuu.jpg?ixlib=rb-4.1.0&#038;rect=0%2C39%2C2370%2C1185&#038;q=45&#038;auto=format&#038;w=1356&#038;h=668&#038;fit=crop" medium="image"></media:content>
	</item>
		<item>
		<title>Health &#124; Pharmacies are tearing cold medicines off their shelves. What options are there now?</title>
		<link>https://bloggingthree.soflytech.com/2024/11/health-pharmacies-are-tearing-cold-medicines-off-their-shelves-what-options-are-there-now/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Tue, 19 Nov 2024 06:22:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cold]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[options]]></category>
		<category><![CDATA[pharmacies]]></category>
		<category><![CDATA[shelves]]></category>
		<category><![CDATA[tearing]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=19390</guid>

					<description><![CDATA[Feeling stuffy and prepared to succeed in for NyQuil, Benadryl, or Sudafed PE? Not so fast. The Food and Drug Administration (FDA) has proposed phasing out the usage of oral phenylephrine, a standard ingredient in lots of cold and allergy medications — and a few pharmacies are already moving to tug the favored products from [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" src="https://www.mercurynews.com/wp-content/uploads/2024/11/Cold_Medicine_48137.jpg?w=1400px&amp;strip=all" /></p>
<div>
<p>Feeling stuffy and prepared to succeed in for NyQuil, Benadryl, or Sudafed PE?</p>
<p>Not so fast.</p>
<p>The Food and Drug Administration (FDA) has proposed phasing out the usage of oral phenylephrine, a standard ingredient in lots of cold and allergy medications — and a few pharmacies are already moving to tug the favored products from shelves.</p>
<p>Florida researchers have been studying the effectiveness of oral phenylephrine for 20 years. Back in 2005, researchers on the University of Florida College of Pharmacy suspected that this ingredient didn&#8217;t relieve nasal congestion, despite the fact that it is often used for this purpose. The researchers evaluated several studies on oral phenylephrine and combined them in a meta-analysis. They concluded that drugs containing this ingredient don&#8217;t work higher than placebo pills in patients with colds and allergic congestion.</p>
<p>&#8220;For 20 years we&#39;ve been telling anyone who will listen that oral phenylephrine doesn&#39;t work,&#8221; he said <a href="https://pharmacy.ufl.edu/profile/hatton-randy/">Randy Hatton</a>Professor on the University of Florida College of Pharmacy. “We taught pharmacy students that it doesn’t work. We hear from pharmacists who know it doesn&#39;t work. And we actually did something about it.”</p>
<p>Hatton and UF Professor, <a href="https://pharmacy.ufl.edu/profile/hendeles-leslie/">Dr. Leslie Hendeles</a>brought their findings to the FDA greater than once. Finally, the federal authority convened a committee in September 2023 and issued a proposed regulation.</p>
<p>“They looked at all the evidence we examined and made an in-depth assessment of what we had been investigating for years,” Hatton said.</p>
<p>The FDA is allowing the general public to comment for the subsequent six months before deciding whether to remove oral phenylephrine medications from the shelves. But some retail pharmacies aren&#39;t waiting. CVS stopped selling products containing phenylephrine last 12 months. Other major pharmacies, including Walgreens and Rite Aid, still carry products containing the drug but say they&#8217;re monitoring the FDA&#39;s actions.</p>
<p>So what options are there for Floridians who are suffering from congestion and don&#39;t have the medications of their alternative?</p>
<p>Hatton said phenylephrine nasal sprays are an option.</p>
<p>&#8220;In spray form, phenylephrine causes constriction of the nose and opens the nasal passages,&#8221; he said. “But only use the sprays for three to five days. People who continue to take them get rebound congestion.”</p>
<p>Doctors and pharmacists also recommend other options:</p>
<ul>
<li>Intranasal steroids reminiscent of Flonase and Nasonex or over-the-counter oxymetazoline nasal sprays reminiscent of Afrin and Zicam</li>
<li>Saline irrigation devices, reminiscent of a neti pot, to assist flush out the sinuses (but only use distilled water, not tap water)</li>
<li>Saline nasal sprays reminiscent of Sinex or Simply Saline, which also use a saltwater solution to flush the sinuses</li>
<li>Products containing pseudoephedrine, the ingredient in Sudafed, will be found behind the pharmacy counter</li>
<li>Oral antihistamines reminiscent of Zyrtec, Allegra, and Claritin, which clear nasal congestion related to allergies</li>
</ul>
<p>“If you have any questions, ask the pharmacists. They are trained in over-the-counter medicines. Just ask: Does this work in traffic jams?” Hatton advises.</p>
<p>Those on the lookout for drug-free options can try:</p>
<ul>
<li>Spicy foods that may cause a burning sensation because of a chemical called capsaicin and cause a runny nose that drains mucus from the sinuses</li>
<li>Steam from a hot shower or a warm compress on the nose</li>
<li>humidifier</li>
</ul>
<p>Originally published: <time datetime="2024-11-18 12:35:10">November 18, 2024 at 12:35 PM PST</time></p>
</div>
<p><em>image credit : www.mercurynews.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://www.mercurynews.com/wp-content/uploads/2024/11/Cold_Medicine_48137.jpg?w=1024&#038;h=666" medium="image"></media:content>
	</item>
		<item>
		<title>European Medicines Agency rejects Alzheimer’s drug Leqembi from Biogen and Eisai</title>
		<link>https://bloggingthree.soflytech.com/2024/07/european-medicines-agency-rejects-alzheimers-drug-leqembi-from-biogen-and-eisai/</link>
		
		<dc:creator><![CDATA[chandankumarsoft]]></dc:creator>
		<pubDate>Fri, 26 Jul 2024 13:36:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[agency]]></category>
		<category><![CDATA[Alzheimers]]></category>
		<category><![CDATA[Biogen]]></category>
		<category><![CDATA[drug]]></category>
		<category><![CDATA[Eisai]]></category>
		<category><![CDATA[European]]></category>
		<category><![CDATA[Leqembi]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[rejects]]></category>
		<guid isPermaLink="false">https://bloggingthree.soflytech.com/?p=10052</guid>

					<description><![CDATA[European Medicines Agency on Friday rejected the Alzheimer treatment Leqembi from Biogen And Eisaiwhich represents one other hurdle for firms in search of to extend acceptance of the therapy within the US The European Commission, the EU&#39;s executive body, has the ultimate say on whether Leqembi must be approved, but it surely almost all the [&#8230;]]]></description>
										<content:encoded><![CDATA[<p></p>
<div id="RegularArticle-ArticleBody-5" data-module="ArticleBody" data-test="articleBody-2" data-analytics="RegularArticle-articleBody-5-2"><span class="HighlightShare-hidden" style="top:0;left:0"></span></p>
<div class="group">
<p>European Medicines Agency on Friday <a href="https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-july-2024" target="_blank" rel="noopener">rejected</a> the Alzheimer treatment Leqembi from <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-3">Biogen<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><button class="AddToWatchlistButton-watchlistButton" aria-label="Add To Watchlist" data-testid="dropdown-btn"><span class="AddToWatchlistButton-addWatchListFromTag"></span></button></span></span></span>    And <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-4">Eisai<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><button class="AddToWatchlistButton-watchlistButton" aria-label="Add To Watchlist" data-testid="dropdown-btn"><span class="AddToWatchlistButton-addWatchListFromTag"></span></button></span></span></span>which represents one other hurdle for firms in search of to extend acceptance of the therapy within the US </p>
<p>The European Commission, the EU&#39;s executive body, has the ultimate say on whether Leqembi must be approved, but it surely almost all the time follows the drug agency&#39;s recommendations. </p>
<p>In a <a href="https://www.globenewswire.com/news-release/2024/07/26/2919489/0/en/Update-on-Regulatory-Review-of-Lecanemab-for-Early-Alzheimer-s-Disease-in-the-European-https://www.globenewswire.com/news-release/2024/07/26/2919489/0/en/Update-on-Regulatory-Review-of-Lecanemab-for-Early-Alzheimer-s-Disease-in-the-European-Union.htmUnion.html" target="_blank" rel="noopener">opinion</a>Eisai said it was &#8220;extremely disappointed&#8221; by the regulator&#39;s negative advice. The company added that it could seek a review of the choice.</p>
<p>Biogen shares fell nearly 7 percent in premarket trading on Friday. Shares of Japanese pharmaceutical company Eisai remained virtually unchanged. </p>
<p>The U.S. Food and Drug Administration approved Leqembi last yr, but its rollout has been slow because of bottlenecks in requirements for diagnostic tests and regular brain scans, amongst other issues. Leqembi has also received regulatory approval in other countries, including Japan, South Korea, China and Israel.</p>
<p>The drug was considered a breakthrough in a progressive disease that&#8217;s notoriously difficult to treat. It is a monoclonal antibody that slows the progression of the disease in early-stage patients. </p>
<p>The Committee for Medicinal Products for Human Use of the European Medicines Agency has really useful not granting marketing authorisation for Leqembi. </p>
<p>In a press release, the committee said that Leqembi&#39;s effect on delaying cognitive decline &#8220;does not outweigh the risk of serious side effects associated with the drug.&#8221; The committee specifically noted the &#8220;frequent occurrence&#8221; of brain swelling and bleeding in patients receiving the drug. </p>
<p>These unintended effects are related to drugs similar to Leqembi and one other monoclonal antibody from <span class="QuoteInBody-quoteNameContainer" data-test="QuoteInBody" id="RegularArticle-QuoteInBody-8">Eli Lilly<span class="QuoteInBody-inlineButton"><span class="AddToWatchlistButton-watchlistContainer" id="-WatchlistDropdown" data-analytics-id="-WatchlistDropdown"><button class="AddToWatchlistButton-watchlistButton" aria-label="Add To Watchlist" data-testid="dropdown-btn"><span class="AddToWatchlistButton-addWatchListFromTag"></span></button></span></span></span>    called Kisunla, which targets and eliminates a toxic plaque within the brain called amyloid, a trademark of Alzheimer&#39;s disease. Kisunla was approved within the U.S. earlier this month. </p>
<p>Leqembi and Kisunla are milestones within the treatment of Alzheimer&#39;s disease after three many years of unsuccessful efforts to develop drugs to treat this deadly disease.</p>
<p>Another ill-fated drug from Biogen and Eisai called Aduhelm struggled to achieve traction within the U.S. after doubts about its approval and data were raised. In 2021, the European Medicines Agency rejected Aduhelm. </p>
<p>Seven million people in Europe suffer from this mentally retarded disease, and that number is anticipated to double by 2050, in line with the nonprofit organization Alzheimer&#39;s Europe. </p>
</div>
</div>
<p><em>image credit : www.cnbc.com</em></p>
]]></content:encoded>
					
		
		
		<media:content url="https://image.cnbcfm.com/api/v1/image/107198777-16771566112023-01-20t224759z_376389922_rc2a2w9juz4s_rtrmadp_0_eisai-biogen-alzheimers-fda.jpeg?v=1698273926&#038;w=1920&#038;h=1080" medium="image"></media:content>
	</item>
	</channel>
</rss>
